About Nuclio Media
The Business Publication of the Nuclear Medicine Economy
Nuclio Media is the leading publication dedicated to the business of nuclear medicine. Through trusted journalism, executive interviews, market analysis, original research, newsletters, webinars, and industry intelligence, it covers the companies, investments, partnerships, regulations, technologies, drugs, and commercial trends shaping the future of the Nuclear Medicine Economy.
Our Mission
Nuclear medicine is one of the fastest-growing sectors in healthcare — yet it has lacked a dedicated business publication that serves the executives, investors, operators, and professionals driving it forward. Nuclio Media was founded to fill that gap. We deliver the intelligence that matters: rigorous reporting, authoritative analysis, and the context needed to make informed decisions in a complex and rapidly evolving industry.
What We Cover
Deals & Partnerships
Acquisitions, licensing agreements, joint ventures, and strategic alliances reshaping the competitive landscape.
Market Analysis
Capital flows, valuations, competitive dynamics, and the financial trends driving the nuclear medicine economy.
Regulation
FDA, NRC, EMA, and global regulatory developments affecting approvals, manufacturing standards, and clinical practice.
Manufacturing & Supply Chain
GMP infrastructure, isotope production, CDMO capacity, and the logistics networks delivering radiopharmaceuticals to patients.
Executive Intelligence
Interviews with C-suite leaders, leadership moves, and the strategic decisions shaping the industry's direction.
Science & Medicine
Clinical trial data, therapeutic and diagnostic advances, and the science underpinning the next generation of nuclear medicine.